研究方向:
1.ncRNA
2.KRAS突变肿瘤发生发展
3.营养与肿瘤微环境
主持或参与科研项目:
1.国家自然基金面上项目,82273001,2023-2026,主持
2.甘肃省重点研发项目,23YFWA0008, 2023-2025,主持
3.中央高校基本科研业务费杰出青年支持计划项目,lzujbky-2024-oy04,2024-2027,主持
3. Cancer Research UK Core Funding,英国癌症研究院重大项目,C5759/A20971,10万英镑,主持
4.双一流高校人才建设经费,561121202,2021-2026,主持
5.甘肃省青年博士基金,2022QB-006,主持(结题)
6.兰州大学医学部优秀青年支持计划(A类支持)2022-2025
7.兰州大学医学研究生培养创新发展项目研究生全英文课程建设项目,主持
8.家畜疫病病原生物学国家重点实验室开发基金,2023-2025,主持
9.横向项目,2024-2025,主持
发表主要论文或专著:
2023年
- 14. Kaixin Yang*, Yinan Xiao*, Linghui Zhong, Wenyang Zhang, Peng Wang, Yaru Ren and Lei Shi. p53-regulated lncRNAs in cancers: from proliferation and metastasis to therapy. Cancer Gene Therapy. 2023. September. doi.org/10.1038/s41417-023-00662-7.
- 13. Kaixin Yang*, Wenyang Zhang*, Linghui Zhong*, Yinan Xiao*, Sudhakar Sahoo, Mateo Fassan, Kang Zeng, Peter Magee, Michela Garofalo, Lei Shi. Long non-coding RNA HIF1A-As2 and MYC form a double positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer. Cell Death and Differentiation. 2023 Apr 11;1-17. doi: 10.1038/s41418-023-01160-x.
2022年
- 12. Yushan Huang*, Longchang Jiang*, Yang Liu, Lixian Liu, Jungling Wang#, Lei Shi#. Long non-coding RNAs in virus-related cancers. Reviews in Medical Virology. 2022;e2364. Doi:10.1002/rmv.2364.
- 11. Kaixin Yang, Chengyun Li, Yang Liu, Xueyan Gu, Longchang Jiang#, Lei Shi#. Prognostic and immunotherapeutic roles of KRAS in Pan-Cancer. Cells. 2022, 11, 1427. Doi.org/10.3390/cells11091427.
2021年
- 10. Lei Shi, Peter Magee, Matteo Fassan, Sudhakar Sahoo, Hui Sun Leong, Dave Lee, Robert Sellers, Laura Brulle-Sumare, Stefano Cairo, Tiziana Monteverde, Stefano Volinia, Duncan Smith, Gianpiero Di Leva, Francesca Galuppini, Athanasios Paliouras, Kang Zeng, Raymond O'Keefe and Michela Garofalo. A KRAS-responsive long non-coding RNA controls microRNA processing. Nature Communications. 2021. 12:2038.doi.org/10.1038/s41467-021-22337.
- 9. Manuela La Montagna, Lei Shi, Peter Magee, Sudhakar Sahoo, Matteo Fassan, Michela Garofalo. AMPKα loss promotes KRAS-mediated lung tumorigenesis. Cell Death & Differentiation.2021 May 26. DOI: 10.1038/s41418-021-00777-0.
2020年
- 8. Lucy Ginn, Manuela La Montagna, Qinghua Wu, Lei Shi. Diverse roles of long non-coding RNA in viral diseases. Reviews in Medical Virology. November 27 2020.DOI:10.1002/RMV.2198 (封面故事).
- 7. Athanasios R. Paliouras*, Marta Buzzetti*, Lei Shi*, Ian J. Donaldson, Peter Magee, Sudhakar Sahoo, Hui-Sun Leong, Matteo Fassan, Matthew Carter, Gianpiero Di Leva, Matthew Krebs, Fiona Blackhall, Christine M. Lovly and Michela Garofalo. Vulnerability of drug-resistance EML4-ALK rearranged lung cancer to transcriptional inhibition. EMBO Molecular Medicine. 2020 Jun 17; e110099. Doi: 10.15252/emmm.201911099 (并列第一作者).
- 6. Lucy Ginn, Lei Shi, Manuela La Montagna and Michela Garofalo. LncRNAs in Non-Small-Cell Lung Cancer. Non-coding RNA, 2020, 6, 25; DOI:10.3390/ncrna6030025.
2018年
- 5. Lei Shi, Justin Middleton, Young-Jun Jeon, Peter Magee, Dario Veneziano, Alessandro Lagana, Hui-Sun Leong, Sudhakar Sahoo, Matteo Fassan, Richard Booton, Rajesh Shan, Philip A.J. Crosbie and Michela Garofalo. KRAS induces lung tumorigenesis through microRNAs modulation. Cell Death & Disease. 2018 Feb 13; 9(2):219.
2017年
- 4. Srivatsava Naidu*, Lei Shi*, Peter Magee, Justin D. Middleton, Alessandro Lagana, Sudhakar Sahoo, HuiSun Leong, Melanie Galvin, Kristopher Frese, Caroline Dive, Vincenza Guzzardo, Metteo Fassan, Michela Garofalo, PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways. Scientific Reports. 2017 Nov 13;7 (1):15441.
2015年
- 3. Peter Magee*, Lei Shi*, Michela Garofalo, Role of microRNAs in chemoresistance. Annals of Translational Medicine, 2015; 3(21): 332.
- 2. Srivatsava Naidu, Lei Shi, Michela Garofalo. MicroRNAs in lung tumorigenesis and chemoresistance, American Association Cancer Research Education Book, 2015: 71-74. DOI: 10.1158/AACR.EDB-15-7984.
2014年
- 1. Lei Shi, Rene Jackstadt, Helge Siemens, Huihui Li, Thomas Kirchner, Heiko Hermeking. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. Cancer Research. 2014 Jan 15; 74(2): 532-42.
专利:
lncRNA ASOs for KRAS Amplified Tumors, 发明人。
一种HIF1A-AS2 特异性反义寡核苷酸及应用,申请,发明人
学生培养情况
指导研究生主持甘肃省优秀研究生“创新之星”项目1项、指导本科生主持“国家级大学生创新创业训练计划” 1项、指导兰州大学生命科学学院本科生主持“兰州大学大学生创新创业计划” 1项、指导研究生主持中央高校基本业务费优秀研究生项目1项